Jung-HwanYoon

Cancer Therapy : Clinical APhase II Study of theEf fi cacy andSafety of theCombination Therapy of theMEK Inhibitor Refametinib ( BAY 86-9766 ) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma

W. Yeo, M. Jeffers, Joong-Won Park, 2014 .

Related Human Hepatocellular Carcinoma − B Virus Based Recurrence Prediction of Hepatitis − Gene Expression

Ju Han Kim, S. Thorgeirsson, Ju-Seog Lee, 2008 .